Armistice Capital »

Evolus shares owned by Armistice Capital

Quarter-by-quarter ownership of Evolus (EOLS) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Evolus

Tip: Access up to 7 years of quarterly data

All positions including Evolus held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Evolus by Armistice Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $3.9M 360k 10.85

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ptc Therapeutics I (PTCT)
Cytokinetics Com New (CYTK)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Incyte Corporation (INCY)
Immunovant (IMVT)
Agios Pharmaceuticals (AGIO)
Argenx Se Sponsored Adr (ARGX)
Novo-nordisk A S Adr (NVO)
Sanofi Sponsored Adr (SNY)
Alkermes SHS (ALKS)
Medtronic SHS (MDT)
Aurinia Pharmaceuticals (AUPH)

View all positions for Armistice Capital

Top funds holding Evolus

Perceptive Advisors
Tang Capital Management
BlackRock
BlackRock
Vanguard Group
Nantahala Capital Management
Caligan Partners
Morgan Stanley
Stonepine Capital Management
State Street Corporation
Geode Capital Management
Dr. Jeffrey R. Jay, M.D.
Soleus Capital Management
Schroder Investment Management Group
D. E. Shaw & Co

View all funds holding Evolus